Safety of Single Rising Doses and Relative Bioavailability of BI 691751

NCT01843972 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 691751
DRUG: BI 691751
DRUG: Placebo
DRUG: BI 691751
DRUG: BI 691751
DRUG: BI 691751
DRUG: BI 691751
DRUG: BI 691751
DRUG: BI 691751
DRUG: BI 691751

Sponsor

Boehringer Ingelheim